This is the protocol for a review and there is noThe objectives are as follows: The main objective of this systematic review is to evaluate the efficacy and safety of low dose cytarabine for patients with MDS.doi:10.1002/14651858.CD009499Kathrin Bauer...
Cytarabine: low-dose, high-dose, no dose? 来自 国家科技图书文献中心 喜欢 0 阅读量: 24 作者: JF Desforges 摘要: PubMed comprises more than 22 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content...
Thirty-four patients with acute myeloid leukemia (AML) in complete remission (CR), 30 of them aged over 60, received maintenance therapy scheduling four courses of low-dose cytarabine (LDA) 20 mg/m 2 /day in two subcutaneous injections for 3 weeks every 6 weeks. Each course was stopped wh...
Of interest in [52] protocol the cumulative dose of chemotherapy is lower for patients with a higher risk strata than for patients with a lower risk strata. This surprising fact is due to the attractiveness of the concept of dose intensification by high-dose chemotherapy. Lower cumulative dose ...
A comparison of low-dose cytarabine and hydroxyurea with or without all-trans retinoic acid for acute myeloid leukemia and high-risk myelodysplastic syndrome in patients not considered fit for intensive treatment. Cancer. 2007; 109 :1114–1124....
4 had received mitoxantrone and cytarabine,pirarubicin and cytarabine regimen for two cycles before but had achieved no remission.Ten of the 28 cases were elderly AML(≥60 years),and CR was noted in 7 of them.Conclusions:The regimen of low dose of homoharringtonine and cytarabine in combination...
Efficacy and safety of decitabine in combination with G-CSF, low-dose cytarabine and aclarubicin in newly diagnosed elderly patients with acute myeloid leu... Efficacy and safety of decitabine in combination with G-CSF, low-dose cytarabine and aclarubicin in newly diagnosed elderly patients with...
In this report, we show for the first time that low-dose lenalidomide has clinical activity when coupled with low-dose Letters to the Editor 969 cytarabine in AML patients aged X70 years, unfit for standard therapy. CR rate was 39.2% among patients evaluable after the first cycle. Patients ...
Efficacy, Prognosis and Safety of Decitabine Combined with Low-Dose Cytarabine in the Treatment of Elderly Patients with Relapsed/Refractory Acute Myeloid LeukemiaChen, D.; Lu, Y.; Yan, R.-Z.; Ye, P.-P.; Zhang, Y.-S.; Ma, J.-X....
low dose cytarabine; etoposide; G-CSF Abstract Backgrounds and objectives The optimal strategy for the management of elderly patients with acute myeloid leukaemia (AML) is still controversial. We previously reported the effectiveness of low dose cytarabine (Ara-C) and etoposide (VP-16) (AV therapy...